Gennex Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
8.47
-0.93 (-9.89%)
BSENSE

Mar 23

BSE+NSE Vol: 11.2 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.47",
    "chg": -0.93,
    "chgp": "-9.89%",
    "dir": -1,
    "prev_price": "9.40",
    "mcapval": "224.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE509C01026",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "11.2 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs83-amid-sector-and-market-downturn-3907844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3907844.png",
        "date": "2026-03-23 12:36:11",
        "description": ""
      },
      {
        "title": "Gennex Laboratories Declines 3.09%: Valuation Shifts and Market Pressures Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-declines-309-valuation-shifts-and-market-pressures-shape-the-week-3905310",
        "imagepath": "",
        "date": "2026-03-21 15:01:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> New 52-week low at Rs.9.3</p>\n                    <p><strong>19 Mar:</strong> Valuation parameters upgraded to very attractive</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.9.40 (-3.09%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.9.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.9.40</div><div class=\"stat-change negative\">-3.09%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Low</div><div class=\"s..."
      },
      {
        "title": "Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-3899552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_valuationdot_3899552.png",
        "date": "2026-03-19 08:00:35",
        "description": "Gennex Laboratories Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a challenging recent performance relative to the broader market. This change is underpinned by improved price-to-earnings and price-to-book value ratios, positioning the micro-cap pharmaceutical player as a compelling consideration within its sector."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.9.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs93-3893725",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3893725.png",
        "date": "2026-03-16 11:32:38",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.9.3 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Falls to 52-Week Low of Rs.9.61",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs961-3890247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3890247.png",
        "date": "2026-03-13 19:59:59",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.9.61 today, marking a significant decline amid broader market weakness and sectoral underperformance."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Falls to 52-Week Low of Rs.9.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs99-3887182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3887182.png",
        "date": "2026-03-12 14:55:51",
        "description": "Gennex Laboratories Ltd’s stock declined to a fresh 52-week low of Rs.9.9 on 12 Mar 2026, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector and broader market weakness. The stock underperformed its sector and key indices, continuing a downward trend that has persisted over the past year."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3884955",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_mojoScore_3884955.png",
        "date": "2026-03-11 10:10:03",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.9.92",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs992-3882904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3882904.png",
        "date": "2026-03-10 13:18:08",
        "description": "Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.9.92 today, marking a significant decline amid broader market fluctuations and sectoral underperformance."
      },
      {
        "title": "Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.10.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs101-3880205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3880205.png",
        "date": "2026-03-09 13:32:39",
        "description": "Gennex Laboratories Ltd’s shares declined sharply to a new 52-week low of Rs.10.1 on 9 March 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market over the past year, reflecting a challenging period for the pharmaceutical and biotechnology firm."
      }
    ],
    "total": 155,
    "sid": "930938",
    "stock_news_url": "https://www.marketsmojo.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Feb-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 announced by the Board of Directors in its meeting held on Saturday February 14 2026. Financial Results had been published in both Business Standard (English) and Saksham ( Telugu-Local) on Monday February 16 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "14-Feb-2026",
      "details": "Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that based on recommendation of Nomination and Remuneration Committee the Board of Directors approved the appointment of Ms. Khushboo Kachhawa (DIN#10872432) as an Additional (Non-Executive & Independent) Women Director of the Company with effect from February 14 2026 subject to approval of the shareholders of the Company. Ms Khushbu Kachhawa will be a Non-Executive & Independent Women Director and she is not related to Promoter or Promoter Group and fulfills the criteria as required under the provisions of the Companies Act 2013 and rules framed thereunder and Listing Regulations. The relevant details and disclosure under Form B enclosed herewith. We request you to take the above information on record and acknowledge the receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Quarter And Nine Months Ended December 31 2025",
      "datetime": "14-Feb-2026",
      "details": "Unaudited (Standalone and Consolidated) Financial Results for 31.12.2025 along with Limited Review Report thereon.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Gennex Laboratories Declines 3.09%: Valuation Shifts and Market Pressures Shape the Week

2026-03-21 15:01:09

Key Events This Week

16 Mar: New 52-week low at Rs.9.3

19 Mar: Valuation parameters upgraded to very attractive

20 Mar: Week closes at Rs.9.40 (-3.09%)

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Feb-2026 | Source : BSE

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 announced by the Board of Directors in its meeting held on Saturday February 14 2026. Financial Results had been published in both Business Standard (English) and Saksham ( Telugu-Local) on Monday February 16 2026. We request you to take the above information on record and acknowledge receipt of the same.

Announcement under Regulation 30 (LODR)-Change in Management

14-Feb-2026 | Source : BSE

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that based on recommendation of Nomination and Remuneration Committee the Board of Directors approved the appointment of Ms. Khushboo Kachhawa (DIN#10872432) as an Additional (Non-Executive & Independent) Women Director of the Company with effect from February 14 2026 subject to approval of the shareholders of the Company. Ms Khushbu Kachhawa will be a Non-Executive & Independent Women Director and she is not related to Promoter or Promoter Group and fulfills the criteria as required under the provisions of the Companies Act 2013 and rules framed thereunder and Listing Regulations. The relevant details and disclosure under Form B enclosed herewith. We request you to take the above information on record and acknowledge the receipt of the same.

Quarter And Nine Months Ended December 31 2025

14-Feb-2026 | Source : BSE

Unaudited (Standalone and Consolidated) Financial Results for 31.12.2025 along with Limited Review Report thereon.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Gennex Laboratories Ltd has announced 1:10 stock split, ex-date: 14 Dec 09

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Gennex Laboratories Ltd has announced 1:2 rights issue, ex-date: 21 Jul 22